Using music and mindfulness in psilocybin therapy for depression
Treatments studied
Part of Mental health clinical trials.
This study tests whether different music and mindfulness preferences affect how well psilocybin (a psychedelic drug) works with psychotherapy for major depression. You would receive psilocybin in a supportive setting and be followed by the study team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 or older.
- You have a diagnosis of major depression (not bipolar or with psychotic features).
- You've tried at least two antidepressant medications for this episode and they didn't fully help.
- You are under a psychiatrist's care and can have them communicate with the study team.
- Your depression is moderate to severe.
- You have a support person (friend or family) who can take you home after the psilocybin sessions.
- You have not used psychedelics more than five times in your life or within the past year.
- You don't have certain heart, seizure, or other medical conditions that could make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This study tests whether a combination of mindfulness training and a single dose of psilocybin can help reduce PTSD symptoms. It is for people with moderate-to-severe PTSD who are not on certain medications and do not have major health problems.
Hear when a new Treatment-Resistant Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.